APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Factor VIII

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Factor VIII Industry Growth and Trends Forecast to 2032

22 December 202592 pages

Choose your research edition.

Industry ResearchRecombinant Factor VIII Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Factor VIII Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Recombinant Factor VIII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Factor VIII Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Factor VIII Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Recombinant Factor VIII market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Factor VIII is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Factor VIII is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Factor VIII is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Factor VIII include Takeda, NovoNordisk, Pfizer, Biogen, Bayer, Octapharma and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Factor VIII market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Factor VIII market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Factor VIII market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Factor VIII.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Factor VIII market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Factor VIII Market by Company

Takeda

NovoNordisk

Pfizer

Biogen

Bayer

Octapharma

CSL

Recombinant Factor VIII Segment by Type

200IU

250IU

Recombinant Factor VIII Segment by Application

Hospital

Pharmacy

Recombinant Factor VIII Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Factor VIII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 200IU Table 2. Major Company of 250IU Table 3. Global Recombinant Factor VIII Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 5. Global Recombinant Factor VIII Sales Market Share in Volume by Type (2021-2026) Table 6. Global Recombinant Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 7. Global Recombinant Factor VIII Sales Market Share in Value by Type (2021-2026) Table 8. Global Recombinant Factor VIII Price by Type (2021-2026) & (US$/unit) Table 9. Global Recombinant Factor VIII Sales by Type (2027-2032) & (units) Table 10. Global Recombinant Factor VIII Sales Market Share in Volume by Type (2027-2032) Table 11. Global Recombinant Factor VIII Sales by Type (2027-2032) & (US$ Million) Table 12. Global Recombinant Factor VIII Sales Market Share in Value by Type (2027-2032) Table 13. Global Recombinant Factor VIII Price by Type (2027-2032) & (US$/unit) Table 14. North America Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 15. North America Recombinant Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 17. Europe Recombinant Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 19. Asia-Pacific Recombinant Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 21. Latin America Recombinant Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Recombinant Factor VIII Sales by Type (2021-2026) & (units) Table 23. Middle East and Africa Recombinant Factor VIII Sales by Type (2021-2026) & (US$ Million) Table 24. Recombinant Factor VIII Industry Trends Table 25. Recombinant Factor VIII Industry Drivers Table 26. Recombinant Factor VIII Industry Opportunities and Challenges Table 27. Recombinant Factor VIII Industry Restraints Table 28. Global Recombinant Factor VIII Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Recombinant Factor VIII Revenue Market Share by Company (2021-2026) Table 30. Global Recombinant Factor VIII Sales by Company (2021-2026) & (units) Table 31. Global Recombinant Factor VIII Sales Share by Company (2021-2026) Table 32. Global Recombinant Factor VIII Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Recombinant Factor VIII Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Recombinant Factor VIII Major Company Production Sites and Headquarters Table 35. Global Recombinant Factor VIII Company, Product Type & Application Table 36. Global Recombinant Factor VIII Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Recombinant Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Recombinant Factor VIII Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Recombinant Factor VIII Sales by Region (2021-2026) & (units) Table 41. Global Recombinant Factor VIII Sales Market Share in Volume by Region (2021-2026) Table 42. Global Recombinant Factor VIII Sales by Region (2021-2026) & (US$ Million) Table 43. Global Recombinant Factor VIII Sales Market Share in Value by Region (2021-2026) Table 44. Global Recombinant Factor VIII Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Recombinant Factor VIII Sales by Region (2027-2032) & (units) Table 46. Global Recombinant Factor VIII Sales Market Share in Volume by Region (2027-2032) Table 47. Global Recombinant Factor VIII Sales by Region (2027-2032) & (US$ Million) Table 48. Global Recombinant Factor VIII Sales Market Share in Value by Region (2027-2032) Table 49. Global Recombinant Factor VIII Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Recombinant Factor VIII Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 52. Global Recombinant Factor VIII Sales Market Share in Volume by Application (2021-2026) Table 53. Global Recombinant Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 54. Global Recombinant Factor VIII Sales Market Share in Value by Application (2021-2026) Table 55. Global Recombinant Factor VIII Price by Application (2021-2026) & (US$/unit) Table 56. Global Recombinant Factor VIII Sales by Application (2027-2032) & (units) Table 57. Global Recombinant Factor VIII Sales Market Share in Volume by Application (2027-2032) Table 58. Global Recombinant Factor VIII Sales by Application (2027-2032) & (US$ Million) Table 59. Global Recombinant Factor VIII Sales Market Share in Value by Application (2027-2032) Table 60. Global Recombinant Factor VIII Price by Application (2027-2032) & (US$/unit) Table 61. North America Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 62. North America Recombinant Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 64. Europe Recombinant Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 66. Asia-Pacific Recombinant Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 68. Latin America Recombinant Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Recombinant Factor VIII Sales by Application (2021-2026) & (units) Table 70. Middle East and Africa Recombinant Factor VIII Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Recombinant Factor VIII Product Portfolio Table 75. Takeda Recent Development Table 76. NovoNordisk Company Information Table 77. NovoNordisk Business Overview Table 78. NovoNordisk Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. NovoNordisk Recombinant Factor VIII Product Portfolio Table 80. NovoNordisk Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Pfizer Recombinant Factor VIII Product Portfolio Table 85. Pfizer Recent Development Table 86. Biogen Company Information Table 87. Biogen Business Overview Table 88. Biogen Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Biogen Recombinant Factor VIII Product Portfolio Table 90. Biogen Recent Development Table 91. Bayer Company Information Table 92. Bayer Business Overview Table 93. Bayer Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Bayer Recombinant Factor VIII Product Portfolio Table 95. Bayer Recent Development Table 96. Octapharma Company Information Table 97. Octapharma Business Overview Table 98. Octapharma Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Octapharma Recombinant Factor VIII Product Portfolio Table 100. Octapharma Recent Development Table 101. CSL Company Information Table 102. CSL Business Overview Table 103. CSL Recombinant Factor VIII Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. CSL Recombinant Factor VIII Product Portfolio Table 105. CSL Recent Development Table 106. North America Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 107. North America Recombinant Factor VIII Sales by Country (2021-2026) & (units) Table 108. North America Recombinant Factor VIII Sales Market Share by Country (2021-2026) Table 109. North America Recombinant Factor VIII Sales Forecast by Country (2027-2032) & (units) Table 110. North America Recombinant Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 111. North America Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Recombinant Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Recombinant Factor VIII Market Share by Country (2021-2026) Table 114. North America Recombinant Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Recombinant Factor VIII Market Share Forecast by Country (2027-2032) Table 116. Europe Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 117. Europe Recombinant Factor VIII Sales by Country (2021-2026) & (units) Table 118. Europe Recombinant Factor VIII Sales Market Share by Country (2021-2026) Table 119. Europe Recombinant Factor VIII Sales Forecast by Country (2027-2032) & (units) Table 120. Europe Recombinant Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Recombinant Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Recombinant Factor VIII Market Share by Country (2021-2026) Table 124. Europe Recombinant Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Recombinant Factor VIII Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Recombinant Factor VIII Sales by Country (2021-2026) & (units) Table 128. Asia-Pacific Recombinant Factor VIII Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Recombinant Factor VIII Sales Forecast by Country (2027-2032) & (units) Table 130. Asia-Pacific Recombinant Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Recombinant Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Recombinant Factor VIII Market Share by Country (2021-2026) Table 134. Asia-Pacific Recombinant Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Recombinant Factor VIII Market Share Forecast by Country (2027-2032) Table 136. Latin America Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 137. Latin America Recombinant Factor VIII Sales by Country (2021-2026) & (units) Table 138. Latin America Recombinant Factor VIII Sales Market Share by Country (2021-2026) Table 139. Latin America Recombinant Factor VIII Sales Forecast by Country (2027-2032) & (units) Table 140. Latin America Recombinant Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Recombinant Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Recombinant Factor VIII Market Share by Country (2021-2026) Table 144. Latin America Recombinant Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Recombinant Factor VIII Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Recombinant Factor VIII Sales by Country (2021-2026) & (units) Table 148. Middle East and Africa Recombinant Factor VIII Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Recombinant Factor VIII Sales Forecast by Country (2027-2032) & (units) Table 150. Middle East and Africa Recombinant Factor VIII Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Recombinant Factor VIII Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Recombinant Factor VIII Market Share by Country (2021-2026) Table 154. Middle East and Africa Recombinant Factor VIII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Recombinant Factor VIII Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Recombinant Factor VIII Distributors List Table 159. Recombinant Factor VIII Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Recombinant Factor VIII Image Figure 2. Global Recombinant Factor VIII Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Factor VIII Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Factor VIII Sales (2021-2032) & (units) Figure 5. 200IU Image Figure 6. Global 200IU Sales YoY Growth (2021-2032) & (units) Figure 7. 250IU Image Figure 8. Global 250IU Sales YoY Growth (2021-2032) & (units) Figure 9. Global Recombinant Factor VIII Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Recombinant Factor VIII Market Share by Type 2025 VS 2032 Figure 11. North America Recombinant Factor VIII Sales Market Share in Volume by Type in 2025 Figure 12. North America Recombinant Factor VIII Sales Market Share in Value by Type in 2025 Figure 13. Europe Recombinant Factor VIII Sales Market Share in Volume by Type in 2025 Figure 14. Europe Recombinant Factor VIII Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Recombinant Factor VIII Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Recombinant Factor VIII Sales Market Share in Value by Type in 2025 Figure 17. Latin America Recombinant Factor VIII Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Recombinant Factor VIII Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Recombinant Factor VIII Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Recombinant Factor VIII Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Recombinant Factor VIII Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (units) Figure 27. Global Recombinant Factor VIII Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Recombinant Factor VIII Market Share by Application 2025 VS 2032 Figure 29. North America Recombinant Factor VIII Sales Market Share in Volume by Application in 2025 Figure 30. North America Recombinant Factor VIII Sales Market Share in Value by Application in 2025 Figure 31. Europe Recombinant Factor VIII Sales Market Share in Volume by Application in 2025 Figure 32. Europe Recombinant Factor VIII Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Recombinant Factor VIII Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Recombinant Factor VIII Sales Market Share in Value by Application in 2025 Figure 35. Latin America Recombinant Factor VIII Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Recombinant Factor VIII Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Recombinant Factor VIII Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Recombinant Factor VIII Sales Market Share in Value by Application in 2025 Figure 39. North America Recombinant Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 40. North America Recombinant Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Recombinant Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Recombinant Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Recombinant Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 44. Europe Recombinant Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Recombinant Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Recombinant Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Recombinant Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 48. Asia-Pacific Recombinant Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Recombinant Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Recombinant Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Recombinant Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 52. Latin America Recombinant Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Recombinant Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Recombinant Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Recombinant Factor VIII Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 56. Middle East and Africa Recombinant Factor VIII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Recombinant Factor VIII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Recombinant Factor VIII Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Recombinant Factor VIII Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Recombinant Factor VIII Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 200IU
  • 250IU
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Takeda
  • NovoNordisk
  • Pfizer
  • Biogen
  • Bayer
  • Octapharma
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Factor VIII Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Factor VIII Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Factor VIII Market by Type
  6. 1.3.1 200IU
  7. 1.3.2 250IU
  8. 1.4 Global Recombinant Factor VIII Market Size by Type
  9. 1.4.1 Global Recombinant Factor VIII Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Recombinant Factor VIII Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Recombinant Factor VIII Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Recombinant Factor VIII Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Recombinant Factor VIII Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Recombinant Factor VIII Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Recombinant Factor VIII Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Recombinant Factor VIII Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Factor VIII Industry Trends
  2. 2.2 Recombinant Factor VIII Industry Drivers
  3. 2.3 Recombinant Factor VIII Industry Opportunities and Challenges
  4. 2.4 Recombinant Factor VIII Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Factor VIII Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Factor VIII Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Factor VIII Price (2021-2026)
  4. 3.4 Global Recombinant Factor VIII Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Factor VIII Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Factor VIII Company, Product Type & Application
  7. 3.7 Global Recombinant Factor VIII Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Factor VIII Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Factor VIII Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Factor VIII Tier 1, Tier 2, and Tier 3
4 Recombinant Factor VIII Regional Status and Outlook
  1. 4.1 Global Recombinant Factor VIII Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Factor VIII Historic Market Size by Region
  3. 4.2.1 Global Recombinant Factor VIII Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Factor VIII Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Factor VIII Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Factor VIII Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Factor VIII Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Factor VIII Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Factor VIII Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Factor VIII by Application
  1. 5.1 Recombinant Factor VIII Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Recombinant Factor VIII Market Size by Application
  5. 5.2.1 Global Recombinant Factor VIII Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Recombinant Factor VIII Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Recombinant Factor VIII Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Recombinant Factor VIII Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Recombinant Factor VIII Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Recombinant Factor VIII Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Recombinant Factor VIII Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Recombinant Factor VIII Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Recombinant Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Recombinant Factor VIII Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 NovoNordisk
  8. 6.2.1 NovoNordisk Company Information
  9. 6.2.2 NovoNordisk Business Overview
  10. 6.2.3 NovoNordisk Recombinant Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 NovoNordisk Recombinant Factor VIII Product Portfolio
  12. 6.2.5 NovoNordisk Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Recombinant Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Recombinant Factor VIII Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Biogen
  20. 6.4.1 Biogen Company Information
  21. 6.4.2 Biogen Business Overview
  22. 6.4.3 Biogen Recombinant Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biogen Recombinant Factor VIII Product Portfolio
  24. 6.4.5 Biogen Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Recombinant Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer Recombinant Factor VIII Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Octapharma
  32. 6.6.1 Octapharma Company Information
  33. 6.6.2 Octapharma Business Overview
  34. 6.6.3 Octapharma Recombinant Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Octapharma Recombinant Factor VIII Product Portfolio
  36. 6.6.5 Octapharma Recent Developments
  37. 6.7 CSL
  38. 6.7.1 CSL Company Information
  39. 6.7.2 CSL Business Overview
  40. 6.7.3 CSL Recombinant Factor VIII Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CSL Recombinant Factor VIII Product Portfolio
  42. 6.7.5 CSL Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Factor VIII Sales by Country
  2. 7.1.1 North America Recombinant Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Factor VIII Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Factor VIII Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Factor VIII Market Size by Country
  6. 7.2.1 North America Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Factor VIII Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Factor VIII Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Factor VIII Sales by Country
  2. 8.1.1 Europe Recombinant Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Factor VIII Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Factor VIII Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Factor VIII Market Size by Country
  6. 8.2.1 Europe Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Factor VIII Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Factor VIII Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Factor VIII Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Factor VIII Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Factor VIII Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Factor VIII Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Factor VIII Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Factor VIII Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Factor VIII Sales by Country
  2. 10.1.1 South America Recombinant Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Factor VIII Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Factor VIII Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Factor VIII Market Size by Country
  6. 10.2.1 South America Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Factor VIII Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Factor VIII Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Factor VIII Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Factor VIII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Factor VIII Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Factor VIII Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Factor VIII Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Factor VIII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Factor VIII Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Factor VIII Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Factor VIII Value Chain Analysis
  2. 12.1.1 Recombinant Factor VIII Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Factor VIII Production Mode & Process
  7. 12.2 Recombinant Factor VIII Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Factor VIII Distributors
  10. 12.2.3 Recombinant Factor VIII Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst